Indefinite Delivery Contract SPE2DP18D0006
Award Date
6/27/18
Last Date to Order
6/26/19
Federal Agency
Medical Supply Chain
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
339112 - Surgical and Medical Instrument Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award SPE2DP24D0005 is a single award indefinite delivery contract with a ceiling value of $2,327,325.00, awarded by the Defense Logistics Agency's Medical Supply Chain to the prime contractor Glaxosmithkline, LLC, doing business as Glaxosmithkline. The contract is for the delivery of influenza virus vaccines, with a period of performance through March 12, 2025. A task order with award ID SPE2DP24D0005|SPE2DP24F3249 was issued on March 14, 2024 for a firm fixed price...
The federal contract IDV award is a $13,916,000 Indefinite Delivery Contract issued by the Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC to provide adult influenza vaccines for the 2025-2026 season. The contract has a period of performance through February 28, 2026. GlaxoSmithKline, a pharmaceutical company that supplies vaccines and other products to federal agencies, will deliver the seasonal flu vaccines under this multiple award IDV contract. The contract vehicle...
The federal contract IDV is a multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs (VA) for the procurement of pharmaceutical products, medical supplies, and vaccines. The contract has a total ceiling value of $3.9 billion and a period of performance through July 31, 2027. The prime contractor is Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company that provides a range of medical products to various federal agencies. Under this IDV,...
The federal contract IDV award is for the procurement of pediatric flu vaccines by the Centers for Disease Control and Prevention (CDC) Pittsburgh, a civilian agency. The prime contractor is Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company that specializes in vaccines, antiviral medications, and other medical countermeasures. The contract has a ceiling value of $182,592,000.00 and a period of performance from December 31, 2024 to February 28, 2026. It is a multiple award,...
This federal contract IDV award to Glaxosmithkline, LLC from the Department of Veterans Affairs (VA) National Acquisition Center procures influenza vaccines for use by the VA, Bureau of Prisons (BOP), Indian Health Service (IHS), and Captain James A. Lovell Federal Health Care Center. The contract has a total estimated annual usage of 306,829 vaccine doses across various product types including 10-dose vials, pre-filled pediatric syringes, and pre-filled syringes for adults 36 months and...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to the pharmaceutical company Glaxosmithkline, LLC to provide pediatric influenza vaccines for the 2024-2025 timeframe. The contract has a ceiling value of $182,592,000 and a period of performance through February 28, 2025. Glaxosmithkline, a foreign-owned for-profit organization, has extensive experience as a prime contractor providing a range of pharmaceutical products and services to...
The federal contract IDV awarded to Glaxosmithkline, LLC is a $83,834,950 Indefinite Delivery Contract to provide a range of adult vaccines to the Centers for Disease Control and Prevention (CDC) for a period of performance through June 30, 2019. The single-award contract was issued without any set-aside designation. The contract aims to procure various pharmaceutical products and immunization services to support public health initiatives, including influenza vaccines, hepatitis vaccines,...
The Defense Logistics Agency Troop Support Medical awarded an Indefinite Delivery Contract to Glaxosmithkline, LLC with a potential value of $50,705,424.00 to supply influenza virus vaccines. Under this contract, three firm fixed price delivery orders were issued for a total of $33,803,616.00 to provide vaccines from Glaxosmithkline's facility in Research Triangle Park, North Carolina. The periods of performance for the delivery orders range from August 31, 2022 through February 24, 2023. The...
The indefinite delivery contract (IDV) with ID 75D30119D05108 was awarded to Glaxosmithkline, LLC by the Centers for Disease Control and Prevention (CDC) for the delivery of adult vaccines. The $112,644,450 multiple award contract, which does not have any set-aside designations, has a period of performance from July 1, 2019 to June 30, 2024. Under this IDV, Glaxosmithkline provides a range of pharmaceutical goods and services as the prime contractor, including influenza virus and hepatitis...
The federal contract IDV award to Glaxosmithkline, LLC is for the supply of pediatric influenza vaccines to the Centers for Disease Control and Prevention (CDC) for distribution to immunization programs under the Section 317(j) Public Health Service Act and Vaccines for Children program. The single-award contract has a ceiling value of $161,025,000 and a period of performance from December 31, 2020 to February 28, 2022. The contract was issued in response to a CDC solicitation for a minimum...